The healthcare research platform has increased its total funding to $102m following a Merck GHI-led round that included Itochu Technology Ventures and Mitsui.

Merck Global Health Innovation (GHI) Fund, a corporate venturing vehicle for pharmaceutical firm Merck & Co, led a $40m series D round for US-based clinical research network operator TriNetX on Wednesday. Diversified conglomerate Mitsui also took part in the round, as did Itochu Technology Ventures, the corporate venturing subsidiary of conglomerate Itochu, as well as…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.